Metacrine | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
Mar 25, 2023 05:29
Metacrine | 8-K: Current report
Mar 25, 2023 05:28
Metacrine | 4: Statement of changes in beneficial ownership of securities-Director Klassen Preston
Mar 25, 2023 00:35
Metacrine | S-8 POS: S-8 POS
Mar 24, 2023 04:34
Metacrine | S-8 POS: S-8 POS
Mar 24, 2023 04:32
Metacrine | 8-K: Current report
Mar 24, 2023 04:31
Metacrine | 8-K: Current report
Mar 16, 2023 05:20
Metacrine | EFFECT: Others
Mar 8, 2023 13:15
Metacrine | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Mar 4, 2023 06:25
Metacrine | 8-K: Current report
Mar 4, 2023 06:23
Metacrine | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Mar 3, 2023 23:44
Metacrine | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(9.98%),Tang Capital Management, LLC(9.98%), etc.
Feb 15, 2023 05:00
Metacrine | DEF 14A: Definitive proxy statements
Feb 13, 2023 21:30
Metacrine | 8-K: Current report
Feb 10, 2023 05:06
Metacrine | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Braden M Leonard(15.9%),BML Investment Partners, L.P.(14.5%)
Feb 9, 2023 04:43
Metacrine | 8-K: Current report
Feb 4, 2023 06:08
Metacrine | 8-K: Current report
Feb 2, 2023 05:16
Metacrine | 4: Statement of changes in beneficial ownership of securities
Jan 28, 2023 05:44
Metacrine | 4: Statement of changes in beneficial ownership of securities
Jan 28, 2023 05:42
Metacrine | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition
Jan 25, 2023 06:17
No Data
No Data